SCHEMBL8687874

SCHEMBL8687874

CCCCOCCCNCC(O)CCCCCCCCCn1c(=O)c2c(ncn2C)n(C)c1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNF P01375 4/20 0.51
▸ ADORA2B P29275 5/20 0.50
▸ PDE4A P27815 2/20 0.50
▸ PDE4B Q07343 2/20 0.50
▸ PDE4C Q08493 2/20 0.50
▸ PDE4D Q08499 2/20 0.50
▸ USP2 O75604 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ NFKB1 P19838 1/20 0.50
▸ ACHE P22303 1/20 0.50
▸ PMP22 Q01453 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ RXFP1 Q9HBX9 1/20 0.50
▸ ADORA2A P29274 1/20 0.47
▸ PDE3A Q14432 2/20 0.45
▸ BCHE P06276 1/20 0.44
▸ CHIT1 Q13231 1/20 0.44
▸ CHIA Q9BZP6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8695168 0.92 ADORA2B (0.54) TNFADORA2BPDE4APDE4BPDE4C
SCHEMBL8006575 0.92 ADORA2B (0.54) TNFADORA2BPDE4APDE4BPDE4C
SCHEMBL8006003 0.92 ADORA2B (0.54) TNFADORA2BPDE4APDE4BPDE4C
SCHEMBL8375264 0.92 ADORA2B (0.54) TNFADORA2BPDE4APDE4BPDE4C
SCHEMBL8003766 0.92 ADORA2B (0.54) TNFADORA2BPDE4APDE4BPDE4C
SCHEMBL2036206 0.92 ADORA2B (0.54) TNFADORA2BPDE4APDE4BPDE4C
SCHEMBL8696212 0.92 ADORA2B (0.54) TNFADORA2BPDE4APDE4BPDE4C
SCHEMBL8375960 0.92 ADORA2B (0.54) TNFADORA2BPDE4APDE4BPDE4C
SCHEMBL7604975 0.92 ADORA2B (0.54) TNFADORA2BPDE4APDE4BPDE4C
SCHEMBL8697911 0.92 ADORA2B (0.54) TNFADORA2BPDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5837703-A AUTOIMMUNE DISEASES, ARTHRITIS, CANCER, LEUKEMIA, MULTIPLE SCLEROSIS; ANTITUMOR AGENTS CELL THERAPEUTICS, INC. (US) 1998-11-17 — — US disclosed
US-5641783-A ANTIINFLAMMATORY OR IMMUNOSUPPRESSIVE AGENTS CELL THERAPEUTICS, INC. (US) 1997-06-24 — — US disclosed
EP-0719267-A1 SECOND MESSENGER CELL SIGNALING INHIBITORS CELL THERAPEUTICS, INC. (US) 1996-07-03 — — EP disclosed
EP-0719267-A4 SECOND MESSENGER CELL SIGNALING INHIBITORS CELL THERAPEUTICS INC (US) 1996-02-16 — — EP disclosed
WO-1994022863-A1 SECOND MESSENGER CELL SIGNALING INHIBITORS CELL THERAPEUTICS, INC. (US) 1994-10-13 — — WO disclosed
Send feedback